Targeted Treatment for Rare Digestive Tract Cancers May Extend Survival Cancer Currents: An NCI Cancer Research Blog, 07 Dec 2018 In an early-phase trial, dabrafenib plus trametinib shrank tumors in patients with biliary tract cancer and adenocarcinoma of…